713 related articles for article (PubMed ID: 19207476)
21. Inhibition of calcium-calmodulin-dependent kinase II suppresses cardiac fibroblast proliferation and extracellular matrix secretion.
Zhang W; Chen DQ; Qi F; Wang J; Xiao WY; Zhu WZ
J Cardiovasc Pharmacol; 2010 Jan; 55(1):96-105. PubMed ID: 19935079
[TBL] [Abstract][Full Text] [Related]
22. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice.
Hiroyama M; Wang S; Aoyagi T; Oikawa R; Sanbe A; Takeo S; Tanoue A
Eur J Pharmacol; 2007 Mar; 559(2-3):89-97. PubMed ID: 17275806
[TBL] [Abstract][Full Text] [Related]
23. Role of heterotrimeric G protein and calcium in cardiomyocyte hypertrophy induced by IGF-1.
Carrasco L; Cea P; Rocco P; Peña-Oyarzún D; Rivera-Mejias P; Sotomayor-Flores C; Quiroga C; Criollo A; Ibarra C; Chiong M; Lavandero S
J Cell Biochem; 2014 Apr; 115(4):712-20. PubMed ID: 24243530
[TBL] [Abstract][Full Text] [Related]
24. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy.
Kashiwase K; Higuchi Y; Hirotani S; Yamaguchi O; Hikoso S; Takeda T; Watanabe T; Taniike M; Nakai A; Tsujimoto I; Matsumura Y; Ueno H; Nishida K; Hori M; Otsu K
Biochem Biophys Res Commun; 2005 Feb; 327(1):136-42. PubMed ID: 15629441
[TBL] [Abstract][Full Text] [Related]
25. A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression.
Calderone A; Abdelaziz N; Colombo F; Schreiber KL; Rindt H
J Mol Cell Cardiol; 2000 Jun; 32(6):1127-40. PubMed ID: 10888263
[TBL] [Abstract][Full Text] [Related]
26. Endothelin-1 induced hypertrophic effect in neonatal rat cardiomyocytes: involvement of Na+/H+ and Na+/Ca2+ exchangers.
Dulce RA; Hurtado C; Ennis IL; Garciarena CD; Alvarez MC; Caldiz C; Pierce GN; Portiansky EL; Chiappe de Cingolani GE; Camilión de Hurtado MC
J Mol Cell Cardiol; 2006 Nov; 41(5):807-15. PubMed ID: 16859700
[TBL] [Abstract][Full Text] [Related]
27. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes.
Nakaoka Y; Nishida K; Fujio Y; Izumi M; Terai K; Oshima Y; Sugiyama S; Matsuda S; Koyasu S; Yamauchi-Takihara K; Hirano T; Kawase I; Hirota H
Circ Res; 2003 Aug; 93(3):221-9. PubMed ID: 12855672
[TBL] [Abstract][Full Text] [Related]
28. 3-[2-[4-(3-Chloro-2-methylphenylmethyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydro-chloride 3.5 hydrate (DY-9760e) is neuroprotective in rat microsphere embolism: role of the cross-talk between calpain and caspase-3 through calpastatin.
Han F; Shirasaki Y; Fukunaga K
J Pharmacol Exp Ther; 2006 May; 317(2):529-36. PubMed ID: 16467455
[TBL] [Abstract][Full Text] [Related]
29. Role of endothelin-1, sodium hydrogen exchanger-1 and mitogen activated protein kinase (MAPK) activation in glucose-induced cardiomyocyte hypertrophy.
Chen S; Khan ZA; Karmazyn M; Chakrabarti S
Diabetes Metab Res Rev; 2007 Jul; 23(5):356-67. PubMed ID: 17024690
[TBL] [Abstract][Full Text] [Related]
30. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
31. Propofol depresses angiotensin II-induced cardiomyocyte hypertrophy in vitro.
Zou XJ; Yang L; Yao SL
Exp Biol Med (Maywood); 2008 Feb; 233(2):200-8. PubMed ID: 18222975
[TBL] [Abstract][Full Text] [Related]
32. Ca²⁺ signal-induced cardiomyocyte hypertrophy through activation of myocardin.
Li M; Wang N; Gong HQ; Li WZ; Liao XH; Yang XL; He HP; Cao DS; Zhang TC
Gene; 2015 Feb; 557(1):43-51. PubMed ID: 25485719
[TBL] [Abstract][Full Text] [Related]
33. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
34. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
[TBL] [Abstract][Full Text] [Related]
35. Urotensin II induction of neonatal cardiomyocyte hypertrophy involves the CaMKII/PLN/SERCA 2a signaling pathway.
Shi H; Han Q; Xu J; Liu W; Chu T; Zhao L
Gene; 2016 May; 583(1):8-14. PubMed ID: 26930364
[TBL] [Abstract][Full Text] [Related]
36. [Role of endothelin-1 and its receptors on hypertrophy or proliferation of cultured cardial cells].
You HW; Chen X; You HJ; Zhang YQ; Cai Y; Liu GZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):520-3. PubMed ID: 16995305
[TBL] [Abstract][Full Text] [Related]
37. Calcium-calmodulin kinase II is the common factor in calcium-dependent cardiac expression and secretion of A- and B-type natriuretic peptides.
Ronkainen JJ; Vuolteenaho O; Tavi P
Endocrinology; 2007 Jun; 148(6):2815-20. PubMed ID: 17332063
[TBL] [Abstract][Full Text] [Related]
38. PPARdelta activation inhibits angiotensin II induced cardiomyocyte hypertrophy by suppressing intracellular Ca2+ signaling pathway.
Lee KS; Park JH; Lee S; Lim HJ; Park HY
J Cell Biochem; 2009 Apr; 106(5):823-34. PubMed ID: 19224536
[TBL] [Abstract][Full Text] [Related]
39. Phenylephrine-induced cardiomyocyte injury is triggered by superoxide generation through uncoupled endothelial nitric-oxide synthase and ameliorated by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxyindazole (DY-9836), a novel calmodulin antagonist.
Lu YM; Han F; Shioda N; Moriguchi S; Shirasaki Y; Qin ZH; Fukunaga K
Mol Pharmacol; 2009 Jan; 75(1):101-12. PubMed ID: 18952768
[TBL] [Abstract][Full Text] [Related]
40. Effects of dl-praeruptorin A on cultured neonatal rat ventricular cardiomyocytes with hypertrophy induced by endothelin-1.
Tu X; Miao L; Kang Y; Xia H; Tu JW; Wang Q; Tu Q; Wang JM; Hao H
Methods Find Exp Clin Pharmacol; 2009 May; 31(4):231-6. PubMed ID: 19557200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
